A true partner in the pursuit of expanded healthspan
Our team of scientists and company-building experts work closely with our pipeline company teams, providing scientific and organizational support for a competitive edge in a rapidly-evolving field. Together, we are advancing breakthrough treatments for age-related diseases with the ultimate goal of creating preventive therapies and extending human healthspan.
Who We Are
We are a dedicated team of scientists and business experts who share a common goal: to improve the quality of life for people all over the world. To do this, we are developing medicines to target the mechanistic drivers of aging, first as treatments and then as preventive medicines.
We are committed to creating a world where people can be physically and mentally healthy for their entire first century of life. We believe that everyone deserves to live a long, healthy, and fulfilling life, free from the limitations of age-related chronic diseases.
How we operate
We are advancing multiple scientific breakthroughs at once by operating as a distributed company (DisCo) with a broad portfolio of pipeline programs. Our pipelines are developed and managed centrally by our dedicated Cambrian team, allowing us to drive innovation and accelerate the development of life-changing treatments.
Big ideas, distilled to practice
Always have a hypothesis
Take bold, measured risks
Be brilliant together
- Big Ideas, Distilled to Practice
- Always Have a Hypothesis
- Take Bold, Measured Risks
- Be Brilliant Together
- Character Matters
“Over the next 10 or 15 years, Cambrian wants to bring the way that we treat the diseases of aging into the 21st century by preventing them from happening, instead of waiting for people to get sick, the same way that we learned how to prevent and reverse the pathologies of infectious diseases like smallpox and polio in the 20th century.”
CEO and Founder of Cambrian Bio
Cambrian’s sourcing and development engine allows us to identify promising science, deploy capital and teams of drug development experts, and provide stewardship to advance new medicines that will lengthen healthspan. By leveraging established expertise and repeatable functional models, we achieve vast efficiencies in execution speed and resource utilization.
Cambrian’s hypothesis-driven approach and industry-leading portfolio of drug candidates provides for multiple “shots on goal” as we endeavor to discover breakthroughs to disrupt the biology of aging – first to treat disease, and ultimately to prevent it.
We combine scientific rigor with an audacious mission: developing transformative, effective and safe therapies to extend healthspan. A crucial aspect of our vision is making these therapies widely available, wherever possible.